Tretazicar (CB 1954), an antitumor proagent, is highly selective against the Walker 256 rat tumour line. Tretazicar is enzymatically activated to generate a bifunctional agent, which can form DNA-DNA interstrand cross-links. Tretazicar in rat cells involves the reduction of its 4-nitro group to a 4-hydroxylamine by the enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1)[1][2].
1309.1RON
În stoc
Număr Catalog 804-HY-13543CategorieAfaceri și industrie > Știință și laboratorFurnizorMedChemExpressGentaurDimensiune5mgTipsingle